The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy

Platelet function tests (PFT), such as the Multiple Electrode Analyzer (Multiplate) and VerifyNow, show little concordance in patients using antiplatelet drugs. A major difference between these tests is the use of prostaglandin E1 (PGE1) to inhibit P2Y1-platelet-receptor activation in VerifyNow and...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Anne-Marije Hulshof, Minka Vries, Paul Verhezen, Rick Wetzels, Mirella Haartmans, Renske Olie, Hugo Ten Cate, Yvonne Henskens
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2021-05-01
Serie:	Platelets
Soggetti:	inhibitor percentage multiplate adp multiplate adp-hs platelet function tests prostaglandin e1 verifynow p2y12
Accesso online:	http://dx.doi.org/10.1080/09537104.2020.1754378
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!